Rachel A. DeWeerd

Rachel A. DeWeerd

Auto-generated profile, based on publicly available information

Rachel A. DeWeerd

Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2022 in Cell Reports
Verified
Journal Article
Open access
RDRachel A. DeWeerd
Rachel A. DeWeerd
ENEszter Németh
Eszter Németh
ÁPÁdám Póti
Ádám Póti
NPNataliya Petryk
Nataliya Petryk
CCChun-Long Chen
Chun-Long Chen
AGAbby M. Green
Abby M. Green
Mutational signatures defined by single base substitution (SBS) patterns in cancer have elucidated potential mutagenic processes that contribute to malignancy. Two prevalent mutational patterns in human cancers are attributed to the APOBEC3 cytidine deaminase enzymes. Among the seven human APOBEC3 proteins, APO-BEC3A is a potent deaminase and proposed driver of cancer mutagenesis. In this study, we prospectively examine genome-wide aberrations by expressing human APOBEC3A in avian DT40 cells. From whole-genome sequencing, we detect hundreds to thousands of base substitutions per genome. The APOBEC3A signature includes widespread cytidine mutations and a unique insertion-deletion (indel) signature consisting largely of cytidine deletions. This multi-dimensional APOBEC3A signature is prevalent in human cancer genomes. Our data further reveal replication-associated mutations, the rate of stem-loop and clustered mutations, and deamination of methylated cytidines. This comprehensive signature of APOBEC3A mutagenesis is a tool for future studies and a potential biomarker for APOBEC3 activity in cancer.

18 October 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
KBKiara N. Berríos
Kiara N. Berríos
NENiklaus H. Evitt
Niklaus H. Evitt
RDRachel A. DeWeerd
Rachel A. DeWeerd
DRDiqiu Ren
Diqiu Ren
MLMeiqi Luo
Meiqi Luo
RKRahul M. Kohli
Rahul M. Kohli

17 June 2024 in The EMBO Journal
Verified
Journal Article
Open access
DFDylan F Fingerman
Dylan F Fingerman
DODavid R O’LEary
David R O’LEary
AHAva R Hansen
Ava R Hansen
TTThi Tran
Thi Tran
BHBrooke R Harris
Brooke R Harris
AGAbby M Green
Abby M Green
Mutational patterns caused by APOBEC3 cytidine deaminase activity are evident throughout human cancer genomes. In particular, the APOBEC3A family member is a potent genotoxin that causes substantial DNA damage in experimental systems and human tumors. However, the mechanisms that ensure genome stability in cells with active APOBEC3A are unknown. Through an unbiased genome-wide screen, we define the Structural Maintenance of Chromosomes 5/6 (SMC5/6) complex as essential for cell viability when APOBEC3A is active. We observe an absence of APOBEC3A mutagenesis in human tumors with SMC5/6 dysfunction, consistent with synthetic lethality. Cancer cells depleted of SMC5/6 incur substantial genome damage from APOBEC3A activity during DNA replication. Further, APOBEC3A activity results in replication tract lengthening which is dependent on PrimPol, consistent with re-initiation of DNA synthesis downstream of APOBEC3A-induced lesions. Loss of SMC5/6 abrogates elongated replication tracts and increases DNA breaks upon APOBEC3A activity. Our findings indicate that replication fork lengthening reflects a DNA damage response to APOBEC3A activity that promotes genome stability in an SMC5/6-dependent manner. Therefore, SMC5/6 presents a potential therapeutic vulnerability in tumors with active APOBEC3A.

4 August 2021 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
AGAbby M Green
Abby M Green
RDRachel A DeWeerd
Rachel A DeWeerd
DODavid R O’LEary
David R O’LEary
AHAva R Hansen
Ava R Hansen
KHKatharina E Hayer
Katharina E Hayer
Matthew WeitzmanMatthew Weitzman
Matthew Weitzman

28 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DODavid R. O’leary
David R. O’leary
AHAva R. Hansen
Ava R. Hansen
DFDylan F. Fingerman
Dylan F. Fingerman
TTThi Tran
Thi Tran
BHBrooke R. Harris
Brooke R. Harris
AGAbby M. Green
Abby M. Green
Mutational patterns caused by APOBEC3 cytidine deaminase activity are evident throughout human cancer genomes. In particular, the APOBEC3A family member is a potent genotoxin that causes substantial DNA damage in experimental systems and human tumors. However, the mechanisms that ensure genome stability in cells with active APOBEC3A are unknown. Through an unbiased genome-wide screen, we define the Structural Maintenance of Chromosomes 5/6 (SMC5/6) complex as essential for cell viability when APOBEC3A is active. We observe an absence of APOBEC3A mutagenesis in human tumors with SMC5/6 dysfunction, consistent with synthetic lethality. Cancer cells depleted of SMC5/6 incur substantial genome damage from APOBEC3A activity during DNA replication. Further, APOBEC3A activity results in replication tract lengthening which is dependent on PrimPol, consistent with re-initiation of DNA synthesis downstream of APOBEC3A-induced lesions. Loss of SMC5/6 abrogates elongated replication tracts and increases DNA breaks upon APOBEC3A activity. Our findings indicate that replication fork lengthening reflects a DNA damage response to APOBEC3A activity that promotes genome stability in an SMC5/6-dependent manner. Therefore, SMC5/6 presents a potential therapeutic vulnerability in tumors with active APOBEC3A.